Good news has come in the wake of the corona virus havoc in India. Canadian company SanoTize has claimed that it has made a nasal spray that kills 99.99 percent of the corona virus. This company claims that this spray will cure sick people from Corona quickly. As per the Canadian company Sanotize, their nasal spray starts eliminating the corona virus in the air. Patients have to put this nitric oxide nasal spray in their nose and it reduces the viral load in the nose. So Sanotize Nitric Oxide Nasal Spray Covid-19 will be another milestone in treating this deadly virus. As we all know that this virus has been doing in India for one month. All the cities whether it is a metro city like Delhi, Mumbai or a small village in Uttar Pradesh are witnessing a huge surge in the case. Every day we are watching more cases than the previous day.
Sanotize Nitric Oxide Nasal Spray
India is currently facing the second deadly wave of coronavirus where around 4 lakh cases are coming up every day. In such a situation, governments are taking various steps to stop the spread of the virus, but in the meantime, scientists are also innovating to prevent this deadly virus. Meanwhile, a Canadian company SanNoTize has claimed that it has made a nasal spray that can kill the coronavirus.
Canadian-based pharmaceutical firm Sanotize has sought emergency approval from the United Kingdom and Canada for the use of its Sanotize Nitric Oxide Nasal Spray Covid-19. And we wish that this spray achieves success so that mankind can get relief from this virus as it has been more than a year since we saw this virus destroying the lives of millions across the globe.
Canadian company Sanotize has claimed to have made a nasal spray that eliminates 99.99 percent of the coronavirus. The company claims that its spray will reduce the time of treatment for people sick with corona. This is called nitric oxide nasal spray. However, it has not yet been approved in India. As a shield and weapon against Covid-19, awaiting emergency approval, this nasal spray can prove to be a game-changer for India. An Israeli scientist has helped develop this spray. In India, it will be great to have this spray after all the drugs our doctors are using on the patients.
Highlights on Nitric Oxide Nasal Spray
|Sanotize Nitric Oxide Nasal Spray
|Yet to be approved
|to kill coronavirus
Sanotize Nitric Oxide Nasal Spray Efficacy
SanNoTize claims that the viral log reduction from the body of people who used their nasal spray during trials was 1.362 in the first 24 hours. In this context, the number of viruses will decrease by 95 percent in a day. It will increase to 99 percent in the next 72 hours and this is the Efficacy of Sanotize Nitric Oxide Nasal Spray. The spray, developed by Vancouver biotech firm SaNOtize, is said to have yielded promising results in the UK and Canada trials against the UK variant.
- Universal Free Vaccine Policy
- Cowin Portal Self Registration
- Cowin App Registration
- Covid Vaccine Certificate Download
- Covid Vaccine Tracker
The company is awaiting approval from regulators around the world for emergency approval. Dr. Gilli Regev, CEO, and Co-founder of Sanotize, says that we are looking for partners in India and hope that this spray will be approved as a medical device in India. He has started talks with some big pharmaceutical companies in India but at this time company has not contacted the government or the regulator.
What happened in the Phase-2 trial?
Nitric oxide nasal spray has been developed by SaNOtize, a biotech company based in Vancouver, Canada and in this, St Peters Hospitals, NHS Foundation Trust, and Berkshire Pathology Services of UK have associated. Dr. Gilli Regev, CEO of SaNOtize claims that nitric oxide can kill any type of virus. This spray sends a small amount of nitric oxide into the nose, which helps in killing the SARS-CoV-2 virus.
Sanotize Nitric Oxide Nasal Spray in India
After the World Health Organization (WHO) recommendation, the government agencies of the countries approve the use of the emergency use authorization of spray. According to Dr. Regev, Israel and Bahrain have approved the use of this spray as a medical device.Dr. Winchester says that the spray makers have sought permission to use emergency in Britain as well and a plan to test its 3rd phase is also being planned.
Whether there is a need for a 3rd stage trial or not, this regulator has to decide. According to him, spray makers are also discussing with some pharmaceutical companies in India. Sanotize wants to do Phase-3 trials with 4-5 thousand people. According to Regev, some parts of Phase-3 trials may also occur in India. They are looking for funding for this. As soon as funding is available, the company will be able to go ahead and conduct trials in India as well.